Christopher Dittus DO, MPH
@cedittus1
Clin. Director Lymphoma Program | Assoc. Professor | UNC Chapel Hill | Clinical Trials | WM | PCNSL | PTLD | ATLL | @unc_lineberger
Have been working w/ @Jmarksloan on this for a decade: BV-CHEP for 1L ATLL. @BrJHaem N=16 CR: 62.5% ORR: 87.5% mOS: 15.7m AlloSCT: 5 pts; mOS: NR Tox: cytopenias, mucositis, PN New consideration for aggressive ATLL. onlinelibrary.wiley.com/doi/epdf/10.11…
Excited to speak at the @DAVAOnc 2025 Bermuda Heme Congress in August! Hope to see you there 👇
🚀 Excited to unveil the agenda for the 2025 DAVA Bermuda Summit on Hematologic Malignancies.🌟 #DAVAHeme will cover the latest data and emerging strategies in multiple myeloma, leukemia, MDS, MPN, and lymphoma. Check out our website! dava.link/BermudaHEME25